Source:http://linkedlifedata.com/resource/pubmed/id/11889183
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2002-3-12
|
pubmed:abstractText |
To study whether antibodies to glutamic acid decarboxylase (GADab) are associated with subclinical beta-cell damage and impaired insulin secretion, we screened 441 nondiabetic patients with autoimmune thyroiditis (AT) for GADab, and 15 (3.4%) were found positive. Antibodies to IA-2 were found in two GADab+ and one GADab- patients. We matched 11 GADab+ and 13 GADab- AT patients who were euthyroid on thyroxin supplementation, and 13 control subjects for sex, age, and body mass index and measured insulin, C-peptide, and glucagon response to glucose and arginine at three blood glucose concentrations (fasting, 14 mmol/liter, >25 mmol/liter). In the fasting state, all groups had similar blood glucose concentration and HbA1c level, but the serum insulin concentration was higher in the AT patients compared with the control subjects (P < 0.04). The acute insulin response to arginine was lower in GADab+ than in GADab- thyroiditis subjects at glucose concentration of 14 and >25 mmol/liter (AIR(14): 76.8 +/- 52.0 vs. 158.2 +/- 118.2 mU/liter, P = 0.040; AIR(>25): 84.3 +/- 64.4 vs. 167.9 +/- 101.5 mU/liter, P = 0.035). In conclusion, GADab were associated with a decreased insulin secretion capacity in nondiabetic subjects with thyroiditis, which suggests that GADab positivity could be a marker of subclinical insulitis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Arginine,
http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide,
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Glutamate Decarboxylase,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1177-83
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11889183-Adult,
pubmed-meshheading:11889183-Aged,
pubmed-meshheading:11889183-Antibodies,
pubmed-meshheading:11889183-Arginine,
pubmed-meshheading:11889183-C-Peptide,
pubmed-meshheading:11889183-Chronic Disease,
pubmed-meshheading:11889183-Female,
pubmed-meshheading:11889183-Follow-Up Studies,
pubmed-meshheading:11889183-Glucagon,
pubmed-meshheading:11889183-Glucose,
pubmed-meshheading:11889183-Glutamate Decarboxylase,
pubmed-meshheading:11889183-Humans,
pubmed-meshheading:11889183-Injections, Intravenous,
pubmed-meshheading:11889183-Insulin,
pubmed-meshheading:11889183-Insulin Resistance,
pubmed-meshheading:11889183-Islets of Langerhans,
pubmed-meshheading:11889183-Male,
pubmed-meshheading:11889183-Middle Aged,
pubmed-meshheading:11889183-Thyroiditis, Autoimmune
|
pubmed:year |
2002
|
pubmed:articleTitle |
Glutamic acid decarboxylase antibody positivity is associated with an impaired insulin response to glucose and arginine in nondiabetic patients with autoimmune thyroiditis.
|
pubmed:affiliation |
Department of Endocrinology, University of Lund, S-205 02 Malmö, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|